Annual Drug Patent Expirations for YUPELRI Yupelri is a drug marketed by Mylan Ireland Ltd and is included in one […]
Source
Annual Drug Patent Expirations for GALAFOLD Galafold is a drug marketed by Amicus Therap Us and is included in one […]
Source
Annual Drug Patent Expirations for BAXDELA Baxdela is a drug marketed by Melinta and is included in two NDAs. It […]
Source
Annual Drug Patent Expirations for VASCEPA Vascepa is a drug marketed by Amarin Pharms and is included in one NDA. […]
Source
Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is […]
Source
New patent expiration for Endo Pharms drug NASCOBAL Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the drugs with the most patents in Singapore. Patents must be filed in each country (or, in […]
Source
Which pharmaceutical drugs have the most drug patents in Singapore? Read Post »
By implementing these strategies, you can can enhance your competitiveness in the market while contributing to increased access to affordable […]
Source
13 Proven Tactics to Outmaneuver Generic Drug Rivals Read Post »
Crafting a Winning Biotech Pitch Deck: A Guide to Securing Investment In the competitive landscape of biotech startups, creating a
In the high-stakes world of pharmaceutical development, effective patent portfolio management can mean the difference between blockbuster success and costly […]
Source
Get new actionable insights and updates from BiotechBlog
